Surgery Partners, Inc. - Common Stock (NQ:SGRY)

13.32 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Surgery Partners, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

1 Mooning Stock with Impressive Fundamentals and 2 We Ignore

April 24, 2026

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a...

Via StockStory

1 Cash-Producing Stock to Target This Week and 2 We Question

April 23, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Via StockStory

Topics Artificial Intelligence

3 Profitable Stocks We Find Risky

April 21, 2026

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...

Via StockStory

Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know

April 17, 2026

What Happened? A number of stocks jumped in the afternoon session after the reopening of the Strait of Hormuz signaled a cooling of global logistics and ener...

Via StockStory

Topics Economy

Surgery Partners Inc (NASDAQ:SGRY) Plummets 22% After Q4 Earnings Miss and Below-Consensus 2026 Guidance ↗

March 02, 2026

Via Chartmill

Topics Earnings

1 High-Flying Stock for Long-Term Investors and 2 We Question

April 07, 2026

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lo...

Via StockStory

3 Reasons to Avoid SGRY and 1 Stock to Buy Instead

April 03, 2026

What a brutal six months it’s been for Surgery Partners. The stock has dropped 42.4% and now trades at $12.18, rattling many shareholders. This was partly dr...

Via StockStory

3 of Wall Street’s Favorite Stocks We Find Risky

March 27, 2026

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

Via StockStory

3 Stocks Under $50 We Keep Off Our Radar

March 20, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Via StockStory

3 Small-Cap Stocks with Warning Signs

March 12, 2026

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...

Via StockStory

Outpatient & Specialty Care Stocks Q4 Highlights: Surgery Partners (NASDAQ:SGRY)

March 08, 2026

Let’s dig into the relative performance of Surgery Partners (NASDAQ:SGRY) and its peers as we unravel the now-completed Q4 outpatient & specialty care earnin...

Via StockStory

Topics Artificial Intelligence

3 Russell 2000 Stocks with Questionable Fundamentals

March 04, 2026

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...

Via StockStory

Which stocks are moving before the opening bell on Tuesday? ↗

March 03, 2026

Via Chartmill

These stocks are moving in today's after hours session ↗

March 02, 2026

Via Chartmill

Surgery Partners’s (NASDAQ:SGRY) Q4 CY2025: Beats On Revenue But Stock Drops 18%

March 02, 2026

Healthcare company Surgery Partners (NASDAQ:SGRY) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.4% year on year to $885 million. On the other hand, the...

Via StockStory

Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 Million ↗

February 23, 2026

This healthcare firm runs a national network of surgical centers, specializing in outpatient procedures across key medical specialties.

Via The Motley Fool

Topics Regulatory Compliance

1 Cash-Producing Stock for Long-Term Investors and 2 We Find Risky

February 19, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

2 Oversold Stocks Set for a Comeback and 1 We Turn Down

February 11, 2026

Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.

Via StockStory

1 Healthcare Stock to Target This Week and 2 We Find Risky

February 04, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their...

Via StockStory

Topics Stocks

3 Small-Cap Stocks with Open Questions

January 12, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

3 Out-of-Favor Stocks We Find Risky

December 24, 2025

The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling...

Via StockStory

2 Healthcare Stocks on Our Watchlist and 1 We Brush Off

December 16, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and...

Via StockStory

Topics Stocks

1 Stock Under $50 with Exciting Potential and 2 We Turn Down

December 10, 2025

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and...

Via StockStory

3 Cash-Producing Stocks We Find Risky

December 02, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

1 of Wall Street’s Favorite Stock Worth Your Attention and 2 We Find Risky

November 25, 2025

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

Alignment Healthcare, Hims & Hers Health, Surgery Partners, Guardant Health, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after a Politico report revealed that the White House plans to pitch a two-year extension of Obamacare subsidies. The proposal would extend subsidies...

Via StockStory

Topics Economy

Zoetis and Surgery Partners Shares Are Soaring, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Earnings Economy

1 of Wall Street’s Favorite Stock on Our Buy List and 2 That Underwhelm

November 21, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

3 Reasons to Sell SGRY and 1 Stock to Buy Instead

November 18, 2025

Surgery Partners has gotten torched over the last six months - since May 2025, its stock price has dropped 35.6% to $15.19 per share. This was partly driven by its softer quarterly results and may have...

Via StockStory

3 Russell 2000 Stocks with Open Questions

November 17, 2025

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...

Via StockStory

Topics Economy

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.